{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:18:31Z","timestamp":1793060311448,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.141273","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T02:53:18Z","timestamp":1739847198000},"page":"141273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"P1","title":["Discovery of effective GSK-3\u03b2 inhibitors as therapeutic potential against Alzheimer's disease: A computational drug design insight"],"prefix":"10.1016","volume":"306","author":[{"given":"Fatemeh Sadat Seyedi","family":"Asl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Malverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mojahedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Baziyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Nabi-Afjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.141273_bb0005","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.3390\/ijms21103676","article-title":"Unravelling the role of glycogen synthase kinase-3 in Alzheimer\u2019s disease-related epileptic seizures","volume":"21","author":"Lin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2019","key":"10.1016\/j.ijbiomac.2025.141273_bb0010","first-page":"321","article-title":"Alzheimer\u2019s disease facts and figures","volume":"15","author":"Gaugler","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0450-3","article-title":"Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study","volume":"11","author":"Hall","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0025","article-title":"Structure and pathology of tau protein in Alzheimer disease","volume":"2012","author":"Kolarova","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0030","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0035","doi-asserted-by":"crossref","unstructured":"E. Lauretti, O. Dincer, D. Pratic\u00f2, Glycogen synthase kinase-3 signaling in Alzheimer's disease, Biochim. Biophys. Acta Mol. Cell Res., 1867 (2020) 118664.","DOI":"10.1016\/j.bbamcr.2020.118664"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer\u2019s disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2006.09.026","article-title":"Age-related changes in glycogen synthase kinase 3\u03b2 (GSK3\u03b2) immunoreactivity in the central nervous system of rats","volume":"409","author":"Lee","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0050","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejmech.2017.11.103","article-title":"Glycogen synthase kinase-3 and its inhibitors: potential target for various therapeutic conditions","volume":"144","author":"Saraswati","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2012.00001","article-title":"GSK-3 and Wnt signaling in neurogenesis and bipolar disorder","volume":"5","author":"Valvezan","year":"2012","journal-title":"Frontiers in molecular neuroscience"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/cancers11040449","article-title":"Role of protein kinases in hedgehog pathway control and implications for cancer therapy","volume":"11","author":"Montagnani","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0065","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mar\u00edtin","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0070","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1080\/07391102.2020.1805362","article-title":"Screening of potential drug for Alzheimer\u2019s disease: a computational study with GSK-3 \u03b2 inhibition through virtual screening, docking, and molecular dynamics simulation","volume":"39","author":"Elangovan","year":"2021","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0075","series-title":"In Silico Screening and In Vitro Evaluation of GSK-3\u03b2 Type I and II Inhibitors: Potential Treatment for Alzheimer\u2019s Disease?","author":"Davies","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0080","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau protein disrupts nucleocytoplasmic transport in Alzheimer\u2019s disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0085","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1007\/s00018-018-2872-2","article-title":"Inhibition of protein misfolding and aggregation by natural phenolic compounds","volume":"75","author":"Dhouafli","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature03194","article-title":"Lessons from natural molecules","volume":"432","author":"Clardy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0100","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1021\/jf000253b","article-title":"Antioxidative activity of green tea treated with radical initiator 2, 2 \u2018-Azobis (2-amidinopropane) dihydrochloride","volume":"48","author":"Yokozawa","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0105","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.43.7.1788","article-title":"In vitro and in vivo activities of tea catechins against helicobacter pylori","volume":"43","author":"Mabe","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(01)00571-7","article-title":"Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells","volume":"170","author":"Uesato","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0115","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0120","doi-asserted-by":"crossref","first-page":"29015","DOI":"10.1039\/D1RA04460E","article-title":"Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow","volume":"11","author":"Goswami","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11030-021-10233-3","article-title":"Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow","volume":"26","author":"Parmar","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0130","article-title":"Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: a computational study validated in vitro on mucormycosis agent","volume":"712","author":"Prajapati","year":"2021","journal-title":"Rhizopus oryzae, Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0135","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/med.20067","article-title":"Combining docking and molecular dynamic simulations in drug design","volume":"26","author":"Alonso","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0140","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s11224-016-0803-0","article-title":"Molecular dynamics study on inhibition mechanism of CDK-2 and GSK-3\u03b2 by CHEMBL272026 molecule","volume":"27","author":"Czele\u0144","year":"2016","journal-title":"Struct. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0145","doi-asserted-by":"crossref","first-page":"45937","DOI":"10.1074\/jbc.M306268200","article-title":"Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418","volume":"278","author":"Bhat","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0150","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2003.11.010","article-title":"GSK-3-selective inhibitors derived from Tyrian purple indirubins","volume":"10","author":"Meijer","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0155","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0165","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0170","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2014a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0175","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0185","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0190","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0195","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0200","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41598-017-02365-0","article-title":"CarcinoPred-EL: novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","article-title":"Glycogen synthase kinase-3 induces Alzheimer\u2019s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase","volume":"147","author":"Hanger","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3940(95)12257-5","article-title":"Exposure of rat hippocampal neurons to amyloid \u03b2 peptide (25\u201335) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I\/glycogen synthase kinase-3\u03b2","volume":"203","author":"Takashima","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2006-9S335","article-title":"GSK-3 is essential in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Takashima","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0220","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0225","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/cells10020262","article-title":"Mechanisms and therapeutic implications of GSK-3 in treating neurodegeneration","volume":"10","author":"Rippin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0230","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jep.2014.01.032","article-title":"Natural potential therapeutic agents of neurodegenerative diseases from the traditional herbal medicine Chinese Dragon\u2019 s blood","volume":"152","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1083\/jcb.200504050","article-title":"Structural properties and neuronal toxicity of amyotrophic lateral sclerosis\u2013associated cu\/Zn superoxide dismutase 1 aggregates","volume":"171","author":"Matsumoto","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0240","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","article-title":"Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation","volume":"585","author":"Ferreira","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0245","first-page":"203","article-title":"Molecular drug targets and therapies for Alzheimer\u2019s disease, translational","volume":"5","author":"Singh","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2008.05.116","article-title":"Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile","volume":"441","author":"Cheng","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0255","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/acschemneuro.0c00376","article-title":"Amentoflavone: a bifunctional metal chelator that controls the formation of neurotoxic soluble A\u03b242 oligomers","volume":"11","author":"Sun","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/cbdd.13067","article-title":"Influence of EGCG on \u03b1-synuclein (\u03b1S) aggregation and identification of their possible binding mode: a computational study using molecular dynamics simulation","volume":"91","author":"Liu","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0265","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/cns.12555","article-title":"7, 8-dihydroxyflavone ameliorates motor deficits via suppressing \u03b1-synuclein expression and oxidative stress in the MPTP-induced mouse model of Parkinson\u2019s disease","volume":"22","author":"Li","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0270","article-title":"Protective effects of flavonoids against Alzheimer\u2019s disease: pathological hypothesis, potential targets, and structure\u2013activity relationship","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2016.08.018","article-title":"Diosmin reduces cerebral A\u03b2 levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice","volume":"299","author":"Sawmiller","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0280","first-page":"1","article-title":"Exploring the anti-amyloid potential of salvianolic acid a against the ALS-associated mutant SOD1: insights from molecular docking and molecular dynamic simulations","author":"Abdullah Waheed","year":"2024","journal-title":"Mol. Simul."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0285","first-page":"1","article-title":"Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation","author":"Noorbakhsh Varnosfaderani","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107967","article-title":"Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant","volume":"107","author":"Qassim","year":"2023","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0295","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10787-023-01215-y","article-title":"Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients\u2019 susceptibility to COVID-19 to the possible caution of future global diabetes tsunami","volume":"31","author":"Sharbatdar","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0300","article-title":"Discovering the therapeutic potential of Naringenin in diabetes related to GLUT4 and its regulatory factors: a computational approach","volume":"10","author":"Khakpour","year":"2024","journal-title":"Chemical Physics Impact"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2022.04.003","article-title":"Green synthesis of silver nanoparticles (AgNPs) by Pistacia terebinthus extract: comprehensive evaluation of antimicrobial, antioxidant and anticancer effects","volume":"608","author":"Naghmachi","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0310","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4858274","article-title":"Evaluation of expression of cytochrome P450 aromatase and inflammatory, oxidative, and apoptotic markers in testicular tissue of obese rats (pre) treated with garlic powder","volume":"2023","author":"Li","year":"2023","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0315","article-title":"The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma","volume":"115914","author":"Ebrahimi","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cancers11010028","article-title":"Flavonoids in cancer and apoptosis","volume":"11","author":"Abotaleb","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0325","doi-asserted-by":"crossref","first-page":"688","DOI":"10.34172\/apb.2023.071","article-title":"Role of GSK-3\u03b2 inhibitors: new promises and opportunities for Alzheimer\u2019s disease","volume":"13","author":"Shri","year":"2023","journal-title":"Advanced Pharmaceutical Bulletin"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0330","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/hmg\/ddp260","article-title":"Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease","volume":"18","author":"Prudencio","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0335","doi-asserted-by":"crossref","unstructured":"P. Priya, M. Kesheri, R.P. Sinha, S. Kanchan, Molecular dynamics simulations for biological systems, pharmaceutical sciences: breakthroughs in research and practice, IGI Global2017, pp. 1044\u20131071.","DOI":"10.4018\/978-1-5225-1762-7.ch040"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0340","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/polym11020282","article-title":"Effects of an electric field on the conformational transition of the protein: a molecular dynamics simulation study","volume":"11","author":"Jiang","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jmgm.2019.06.008","article-title":"Identification of novel small molecules against GSK3\u03b2 for Alzheimer\u2019s disease using chemoinformatics approach","volume":"91","author":"Shukla","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0350","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203715666140327114232","article-title":"A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states","volume":"15","author":"Ausaf Ali","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0355","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01998","article-title":"Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6","volume":"3","author":"Stamos","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0360","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3\u03b2: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2020.105660","article-title":"Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis","volume":"195","author":"Al-Khafaji","year":"2020","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0370","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/joim.12732","article-title":"Amyloid fibril polymorphism: a challenge for molecular imaging and therapy","volume":"283","author":"F\u00e4ndrich","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0375","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nrd4128","article-title":"Chemical predictive modelling to improve compound quality","volume":"12","author":"Cumming","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0380","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/tx900326k","article-title":"Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species","volume":"23","author":"Fourches","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21894","article-title":"Multifunctional effect of flavonoids from Millettia brandisiana against Alzheimer's disease pathogenesis","volume":"9","author":"Arsito","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0390","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11662-7","article-title":"6-bromo-indirubin-3\u2032-oxime (6BIO), a glycogen synthase kinase-3\u03b2 inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts","volume":"7","author":"Sklirou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0395","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","article-title":"Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model","volume":"102","author":"Garcia-Alloza","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0400","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126684","article-title":"Unveiling promising inhibitors of superoxide dismutase 1 (SOD1) for therapeutic interventions","volume":"253","author":"Atiya","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0410","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1073\/pnas.1220326110","article-title":"Insights into antiamyloidogenic properties of the green tea extract (\u2212)-epigallocatechin-3-gallate toward metal-associated amyloid-\u03b2 species","volume":"110","author":"Hyung","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0415","first-page":"1198","article-title":"Myricetin: a naturally occurring regulator of metal-induced amyloid-\u03b2 aggregation and neurotoxicity","volume":"12","author":"DeToma","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.50","article-title":"A natural BACE1 and GSK3\u03b2 dual inhibitor Notopterol effectively ameliorates the cognitive deficits in APP\/PS1 Alzheimer\u2019s mice by attenuating amyloid-\u03b2 and tau pathology","volume":"10","author":"Jiang","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102200","article-title":"GSK-3\u03b2 as a target for apigenin-induced neuroprotection against A\u03b2 25\u201335 in a rat model of Alzheimer's disease","volume":"90","author":"Alsadat","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0430","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2018.03.028","article-title":"Rosmarinic acid attenuates \u03b2-amyloid-induced oxidative stress via Akt\/GSK-3\u03b2\/Fyn-mediated Nrf2 activation in PC12 cells","volume":"120","author":"Rong","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0435","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0440","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.biomaterials.2010.10.027","article-title":"Curcumin-decorated nanoliposomes with very high affinity for amyloid-\u03b21-42 peptide","volume":"32","author":"Mourtas","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.afnr.2016.12.008","article-title":"Nanotechnology approaches for increasing nutrient bioavailability","volume":"81","author":"Jafari","year":"2017","journal-title":"Adv. Food Nutr. Res."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0450","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ijms22010196","article-title":"Curcumin and its derivatives as theranostic agents in Alzheimer\u2019s disease: the implication of nanotechnology","volume":"22","author":"Shabbir","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119476","article-title":"Neuroprotection by curcumin: a review on brain delivery strategies","volume":"585","author":"Askarizadeh","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0460","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcis.2010.10.024","article-title":"Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo","volume":"354","author":"Song","year":"2011","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122102","article-title":"Biomedical applications and bioavailability of curcumin\u2014an updated overview","volume":"13","author":"Sohn","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0470","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","article-title":"Curcumin and its nano-formulation: the kinetics of tissue distribution and blood\u2013brain barrier penetration","volume":"416","author":"Tsai","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0475","article-title":"Curcumin inhibits the growth via Wnt\/\u03b2-catenin pathway in non-small-cell lung cancer cells","volume":"22","author":"Wang","year":"2018","journal-title":"European Review for Medical & Pharmacological Sciences"},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0480","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ptr.5791","article-title":"Curcumin suppresses lung cancer stem cells via inhibiting Wnt\/\u03b2-catenin and sonic hedgehog pathways","volume":"31","author":"Zhu","year":"2017","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ijbiomac.2025.141273_bb0485","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1080\/07391102.2021.1977705","article-title":"Screening of Azadirachta indica phytoconstituents as GSK-3\u03b2 inhibitor and its implication in neuroblastoma: molecular docking, molecular dynamics, MM-PBSA binding energy, and in-vitro study","volume":"40","author":"Chandel","year":"2022","journal-title":"Journal of Biomolecular Structure and Dynamics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025018227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025018227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:47:02Z","timestamp":1782902822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025018227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":97,"alternative-id":["S0141813025018227"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141273","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of effective GSK-3\u03b2 inhibitors as therapeutic potential against Alzheimer's disease: A computational drug design insight","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141273"}}